Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed Feb 14, 2024 · 10-Q · 45 days after period end · 0001477932-24-000713
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$1.20M | -$1.29M | -$5.53M | -$1.19M |
| EPS Diluted | $0.00 | — | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Feb 14, 2024 · 45 d after period end
